Gilead Sciences Files Trademark for Its Coronavirus Drug Bottle

Gilead Sciences has filed a new trademark application for the design of a bottle to be used in connection with “pharmaceutical preparations for the treatment of coronavirus.”

The application was submitted with the USPTO on March 26 and filed on a 1(b) basis. This means that the pharmaceutical giant has a bona fide intent to use the trademark in association with the goods listed in the application.

This type of application is actually called a “trade dress” application because Gilead Sciences is attempting to protect the look and feel of a bottle. In the technical drawing that was submitted, Gilead makes no claim to the shape of the bottle, but rather the size and placement of the label, as well as the blue and gray cap.

In a co-pending application for this bottle design (filed on the same day), Gilead indicated that it has been using this bottle design for over 10 years in conjunction with other drugs.  The filing mentioned in the video above is significant because it singles out this bottle design specifically for use in association with a coronavirus treatment. The hope here is that Gilead filed this application because it is optimistic about being able to market its remdesivir drug as a therapy for the novel coronavirus.

• SHARE THIS ARTICLE ON:

Josh Gerben, Esq.

Josh Gerben, Esq. is a nationally recognized trademark attorney and the founder of Gerben IP. Since launching the firm in 2008, he has overseen the registration of over 10,000 trademarks and handled over 1,500 trademark disputes. Josh's practice focuses on building and defending global trademark portfolios for clients. These clients include entrepreneurs, private equity-backed businesses, athletes, celebrities, and public companies. Frequently quoted by major media outlets like CNBC, CNN, The New York Times, and The Wall Street Journal, Josh is widely regarded as a leading authority in trademark law.